Correction to: Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1897-4287

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Correction to: Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants ; volume:19 ; number:1 ; day:8 ; month:9 ; year:2021 ; pages:1 ; date:12.2021
Hereditary cancer in clinical practice ; 19, Heft 1 (8.9.2021), 1, 12.2021

Creator: Murali, Krithika
Dwarte, Tanya M.
Nikfarjam, Mehrdad
Tucker, Katherine M.
Vaughan, Rhys B.
Efthymiou, Marios
Collins, Allison
Spigelman, Allan D.
Salmon, Lucinda
Johns, Amber L.
Williams, David B.
Delatycki, Martin B.
John, Thomas
Stoita, Alina

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13053-021-00195-w

URN: urn:nbn:de:101:1-2021112220052457113688

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:25 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Murali, Krithika
Dwarte, Tanya M.
Nikfarjam, Mehrdad
Tucker, Katherine M.
Vaughan, Rhys B.
Efthymiou, Marios
Collins, Allison
Spigelman, Allan D.
Salmon, Lucinda
Johns, Amber L.
Williams, David B.
Delatycki, Martin B.
John, Thomas
Stoita, Alina
SpringerLink (Online service)

Other Objects (12)

Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants

Clinically significant germline pathogenic variants are missed by tumor genomic sequencing

Characterization of pathogenic germline mutations in human Protein Kinases

Potential pathogenic germline variant reporting from tumor comprehensive genomic profiling complements classic approaches to germline testing

Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study

Unusual phenotypes in patients with a pathogenic germline variant in DICER1

Prevalence of pathogenic germline variants in the circulating tumor DNA testing

Evolutionary origin of germline pathogenic variants in human DNA mismatch repair genes

Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing

Genetic testing and management of prostate cancer patients with pathogenic germline variants

High-risk pathogenic germline variants in blood relatives of BRCA1/2 negative probands

Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants

Clinically significant germline pathogenic variants are missed by tumor genomic sequencing

Characterization of pathogenic germline mutations in human Protein Kinases

Potential pathogenic germline variant reporting from tumor comprehensive genomic profiling complements classic approaches to germline testing

Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study

Unusual phenotypes in patients with a pathogenic germline variant in DICER1

Prevalence of pathogenic germline variants in the circulating tumor DNA testing

Evolutionary origin of germline pathogenic variants in human DNA mismatch repair genes

Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing

Genetic testing and management of prostate cancer patients with pathogenic germline variants

High-risk pathogenic germline variants in blood relatives of BRCA1/2 negative probands

Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants

Clinically significant germline pathogenic variants are missed by tumor genomic sequencing

Characterization of pathogenic germline mutations in human Protein Kinases

Potential pathogenic germline variant reporting from tumor comprehensive genomic profiling complements classic approaches to germline testing

Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study

Unusual phenotypes in patients with a pathogenic germline variant in DICER1

Prevalence of pathogenic germline variants in the circulating tumor DNA testing

Evolutionary origin of germline pathogenic variants in human DNA mismatch repair genes

Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing

Genetic testing and management of prostate cancer patients with pathogenic germline variants

High-risk pathogenic germline variants in blood relatives of BRCA1/2 negative probands

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Correction to: Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants

Clinically significant germline pathogenic variants are missed by tumor genomic sequencing

Characterization of pathogenic germline mutations in human Protein Kinases

Potential pathogenic germline variant reporting from tumor comprehensive genomic profiling complements classic approaches to germline testing

Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study

Unusual phenotypes in patients with a pathogenic germline variant in DICER1

Unusual phenotypes in patients with a pathogenic germline variant in DICER1

Prevalence of pathogenic germline variants in the circulating tumor DNA testing

Evolutionary origin of germline pathogenic variants in human DNA mismatch repair genes

Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing

Genetic testing and management of prostate cancer patients with pathogenic germline variants

High-risk pathogenic germline variants in blood relatives of BRCA1/2 negative probands

Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants

Clinically significant germline pathogenic variants are missed by tumor genomic sequencing

Characterization of pathogenic germline mutations in human Protein Kinases

Potential pathogenic germline variant reporting from tumor comprehensive genomic profiling complements classic approaches to germline testing

Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study

Unusual phenotypes in patients with a pathogenic germline variant in DICER1

Unusual phenotypes in patients with a pathogenic germline variant in DICER1

Prevalence of pathogenic germline variants in the circulating tumor DNA testing

Evolutionary origin of germline pathogenic variants in human DNA mismatch repair genes

Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing

Genetic testing and management of prostate cancer patients with pathogenic germline variants

High-risk pathogenic germline variants in blood relatives of BRCA1/2 negative probands

Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants

Clinically significant germline pathogenic variants are missed by tumor genomic sequencing

Characterization of pathogenic germline mutations in human Protein Kinases

Potential pathogenic germline variant reporting from tumor comprehensive genomic profiling complements classic approaches to germline testing

Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study

Unusual phenotypes in patients with a pathogenic germline variant in DICER1

Unusual phenotypes in patients with a pathogenic germline variant in DICER1

Prevalence of pathogenic germline variants in the circulating tumor DNA testing

Evolutionary origin of germline pathogenic variants in human DNA mismatch repair genes

Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing

Genetic testing and management of prostate cancer patients with pathogenic germline variants

High-risk pathogenic germline variants in blood relatives of BRCA1/2 negative probands

Related objects

Reset password